These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12654462)

  • 1. In regard to hyperfractionation for non-small-cell lung cancer: fire, ready, aim!
    Beitler JJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1460; author reply 1460-1. PubMed ID: 12654462
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoradiation paradigm for the treatment of lung cancer.
    Eberhardt W; Pöttgen C; Stuschke M
    Nat Clin Pract Oncol; 2006 Apr; 3(4):188-99. PubMed ID: 16596143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European perspectives on paclitaxel/platinum-based therapy for advanced non-small cell lung cancer.
    Novello S; Le Chevalier T
    Semin Oncol; 2001 Aug; 28(4 Suppl 14):3-9. PubMed ID: 11605176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboplatin/etoposide/radiation plus escalating doses of paclitaxel in stage III non-small cell lung cancer: a preliminary report.
    Bonomi P; Faber LP; Recine D; Lincoln S
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):42-7. PubMed ID: 7644927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage III nonsmall cell lung cancer: still a challenge for the radiation oncologist.
    Van Houtte P
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):533-5. PubMed ID: 9336128
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current data concerning neoadjuvant chemotherapy].
    Depierre A
    Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S11-3. PubMed ID: 16719148
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction chemotherapy with cisplatin, etoposide and vindesine before radiation therapy for nonsmall-cell lung cancer. A randomized study.
    Van Houtte P; Klastersky J; Renaud A; Michel J; Vandermoten G; Nguyen H; Sculier JP; Devriendt J; Mommen P
    Antibiot Chemother (1971); 1988; 41():131-7. PubMed ID: 2854432
    [No Abstract]   [Full Text] [Related]  

  • 8. Concurrent paclitaxel, carboplatin, and radiation therapy for locally advanced non-small cell lung cancer.
    Choy H; Akerley W; DeVore RF
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):36-43. PubMed ID: 10190782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial.
    Jeremic B; Shibamoto Y; Acimovic L; Milicic B; Milisavljevic S; Nikolic N; Dagovic A; Aleksandrovic J; Radosavljevic-Asic G
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):19-25. PubMed ID: 11316542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions.
    Bunn PA
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-153-S12-162. PubMed ID: 9331142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of unresectable non-small-cell lung cancer].
    Ueoka H
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):356-61. PubMed ID: 10740628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
    Belani CP
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin vs. carboplatin-based chemoradiotherapy in patients >65 years of age with stage III non-small cell lung cancer.
    Ezer N; Smith CB; Galsky MD; Mhango G; Gu F; Gomez J; Strauss GM; Wisnivesky J
    Radiother Oncol; 2014 Aug; 112(2):272-8. PubMed ID: 25150635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of inoperable non-small cell lung cancer: induction chemotherapy or hyperfractionated radiotherapy? Apropos of 2 recent therapeutic trials].
    Reboul F; Vincent P; Chauvet B; Brewer Y; Taulelle M
    Cancer Radiother; 1998; 2(3):287-9. PubMed ID: 9749128
    [No Abstract]   [Full Text] [Related]  

  • 15. Paclitaxel, carboplatin and radiation therapy for non-small-cell lung cancer.
    Choy H; Akerley W; Devore R
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 2):80-6. PubMed ID: 9516618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancer.
    Greco FA; Stroup SL; Gray JR; Hainsworth JD
    J Clin Oncol; 1996 May; 14(5):1642-8. PubMed ID: 8622083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: a meta-analysis.
    Pignon JP; Stewart LA
    Cancer; 1996 Jun; 77(11):2413-4. PubMed ID: 8635115
    [No Abstract]   [Full Text] [Related]  

  • 18. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel/carboplatin in the treatment of non-small-cell lung cancer.
    Belani CP
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 2):74-9. PubMed ID: 9516617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
    Belani CP
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.